Fusion Antibodies plc (AIM:FAB)
London · Delayed Price · Currency is GBP · Price in GBX 14.50
0.00 (0.00%)
At close: Dec 5, 2025
Fusion Antibodies Market Cap
Fusion Antibodies has a market cap or net worth of 16.48 million as of December 5, 2025. Its market cap has increased by 304.12% in one year.
Market Cap
16.48M
Enterprise Value
16.62M
Revenue
1.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
14.50
Market Cap Chart
Since December 18, 2017, Fusion Antibodies's market cap has decreased from 27.28M to 16.48M, a decrease of -39.59%. That is a compound annual growth rate of -6.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 16.48M | 143.62% |
| Dec 31, 2024 | 6.76M | 167.72% |
| Dec 29, 2023 | 2.53M | -78.42% |
| Dec 30, 2022 | 11.71M | -59.09% |
| Dec 31, 2021 | 28.62M | -9.27% |
| Dec 31, 2020 | 31.54M | 81.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 18, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.77B |
| GSK plc | 72.45B |
| Haleon | 32.12B |
| Smith & Nephew | 10.72B |
| Convatec Group | 4.49B |
| Hikma Pharmaceuticals | 3.53B |
| HUTCHMED (China) | 1.84B |
| Genus | 1.73B |